Clinical trial
PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
NCT05803746
Study timeline
Study start (actual)2022-07-15Date precision: day
Registry last updated2023-04-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Colorectal Cancerunresolved
Interventions
18F-FDGDRUG
Sponsors & collaborators
Peking University Cancer Hospital & Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05803746 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.